For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samplesserum, plasma, cell culture supernatants and cell lysatesindicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Scope of the Report:
The global average price of ELISA is in the decreasing trend, from 211 USD /Unit in 2011 to 196 USD/ Unit in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.
the classification of ELISA includes ELISA Sets ELISA Kits, and the proportion of ELISA Kits in 2015 is about 61%.ELISA is widely used in IVD testing field.
USA is the largest supplier of ELISA, with a production market share nearly 48% in 2015. Europe is the second largest supplier of ELISA, enjoying production market share nearly 34% in 2015.
North america is the largest consumption place, with a consumption market share nearly 40% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 26%. China is the world's largest import country.
market competition is not intense. R&D Systems and Thermo Fisher Scientific, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Enzyme-Linked Immunosorbent Assay (ELISA) is expected to grow at a CAGR of roughly 3.5% over the next five years, will reach 200 million US$ in 2024, from 160 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Enzyme-Linked Immunosorbent Assay (ELISA) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- R&D Systems
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- BD Biosciences
- ZEUS Scientific
- Bio-Rad Laboratories
- ALPCO
- Enzo Life Sciences
- BioMérieux
- EMD Millipore
- BioLegend
- LOEWE Biochemica
- Shenzhen YHLO Biotech
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- ELISA Sets
- ELISA Kits
Market Segment by Applications, can be divided into
- ELISA in HIV
- ELISA in West Nile Virus
- Detecting Antigens or Antibodies
- Biodefense
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), with price, sales, revenue and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) in 2017 and 2018.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enzyme-Linked Immunosorbent Assay (ELISA) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Enzyme-Linked Immunosorbent Assay (ELISA) sales channel, distributors, customers, research findings and conclusion, appendix and data source.